The Bombay Exhibition Centre in Mumbai welcomed industry leaders to the 8th edition of PharmaLytica Expo on 1st June 2022. Mr. K. G. Ananthakrishnan, Director General – OPPI, Mr. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, Mr. Chakravarthi AVPS Garu, Global Ambassador – World Packaging Organisation & Director on Board for Pharmaceutical Export Promotion Council, and Mr. Rahul Deshpande, Group Director, Informa Markets in India were among the dignitaries who attended the event's grand opening. All industry professionals, including domain stalwarts, pharma leaders, technical heads & plant heads, medical heads & scientists, marketing & strategy leaders, R&D heads and technocrats, engineering & production professionals, purchase & packaging professionals, Regulatory Affairs professionals, and others, can benefit from the annual three-day exhibition. 

Over 7000 trade visitors are expected over the three days, with over 300 brands displaying their latest advances and 30 conference speakers. Shimadzu, Thermolab, Agilent, Saksham Scientific, SRICO, Newtronics, Mack Pharmatech, Sanosil Biotech, Toshvin Analytical, PCI Analytics, Sanitt Equipment, Elmach, Parle Global, and many others are among the major companies. The Pharmaceutical Export Promotion Council of India, IDMA, and CiPi are all supporting the event. 

On the occasion of the 8th edition of PharmaLytica, Mr. Yogesh Mudras, Managing Director, Informa Markets, India said,?“Over these three days, the PharmaLytica Expo will facilitate one-to-one meetings for industry stalwarts’ and trade professionals to exchange ideas, grow business, display innovation and technology, skills, experience, and thoughts and trigger novel ideas on manufacturing. Today pharma is recognized as a well-entrenched sector for our country’s economy and is anticipated to grow threefold in the decade. While it is expected to be a $65 billion industry by 2024, with weighty contributions toward generics, the pharmaceutical industry is all set to further extend its R&D capabilities and offer cutting-edge products in a post-pandemic world.”  

“We are sure that with the breadth of innovation and insights on offer at the expo, our buyer and seller community will be armed with new concepts, ideas and solutions to help them design and manufacture ever more innovative solutions,” he further added.  

Speaking at the inauguration, Mr. KG Ananthakrishnan, DG – OPPI said, “The pharmaceutical market is set to grow from its current levels of $50Bn to US$130Bn by 2030 growing at a CAGR of 12.3%. This target can be achieved by having a global outlook looking at Asian geographies along with existing completive advantage in various industries, favorable factors of production, conducive business environment, and incentivized government policies. Along with these factors, Digital transformation across the entire value chain is vital for enhanced patient care, greater transparency, cost-effectiveness, improved production and drug development. Latest technologies such as artificial intelligence (AI), AR/VR, Block Chain, machine learning (ML) and additive manufacturing are helping pharma companies to improve the R&D process, conducting clinical tests in less time and adding innovation to the products while improving compliance and efficiencies in manufacturing and inventory management.”  

The healthcare business has raised quality standards and is rapidly transitioning to digitalization. The PharmaLytica Conference 2022 will cover subjects such as digitalization challenges and possibilities, strategies for maintaining a global supply chain in a constrained context, and novel analysis methods for optimising laboratory procedures, transforming labs into smart technology labs. The two-day conference is an invite-only event that will showcase important industry stalwarts' plans for charting the next chapter of pharma growth. API, machinery and production, lab & analytical, QR Code, supply chain, packaging and labelling, AI, IoT, Blockchain, Bigdata in Pharma, Pharma Supply Chain, Packaging & Labeling, Serialization, and Track & Trace were among the subjects discussed at the conference. The well-organized show also covered essential issues of global pharmaceutical manufacture.